THE cause of a Brit model’s death just days after being given the AstraZeneca vaccine may never be known, a health chief warns.
Stephanie Dubois, 39, suffered a “serious thrombotic episode” after being given the jab in the town of Paphos, Cyprus.
She died on Saturday afternoon following a brain haemorrhage, according to local media reports.
Charalambos Charilaou, Cypriot health service spokesman, said her death would be investigated by the European Medicines Agency (EMA).
But it has not been confirmed yet if it is linked to the jab.
Elena Panayiotopoulou, acting director of pharmaceutical services at the Ministry of Health in Nicosia, the island’s capital, said the model’s cause of death may never be known.
“We may never be sure that her death is linked to the AstraZeneca vaccine,” she told The Sun Online.
“What she suffered is very, very rare although we do know that thrombosis cytopenia syndrome can also be suffered by people who have not had the vaccine.
“A lot of further investigation needs to be conducted to see if there is any correlation between the two incidents.
“We have sent all our findings to the European Medicines Agency who will make that assessment… and they may never make a conclusion based on one incident, which means we may never know if there is any link.”
Dubois received the first dose of the vaccination on May 6 and posted on Facebook: “So I had the vaccination today! I hate needles, today was no exception… And now I feel horrendous… pizza and bed for me.”
She was then taken to hospital on May 14 with breathing problems.
She wrote: “Woke up feeling fine and then within an hour I had full body shakes, all my joints seized and I was struggling to breathe and was cold to the bone with a persistent headache and dizziness.
“Mum and dad came to look after me and took me for a Covid test, which thankfully was negative… but it still doesn’t explain what the problem is. Maybe I’m having a prolonged reaction to my Covid jab last week.”
By May 19, she had slipped into a coma and “was not expected to come out of it”, according to pal Andrew Powers.
Health officials at Cyprus’s main state hospital in Nicosia said she had no underlying health conditions.
‘BENEFITS OUTWEIGH RISKS’
In March, Cyprus suspended AstraZeneca shots pending a review by the EMA.
Germany, France and other EU member states followed suit but re-introduced the jab on March 18.
Only two other people in Cyprus developed blood clots after the AstraZeneca vaccination. Both had underlying health issues and neither died.
In April, the EMA confirmed that the benefits of the AstraZeneca/Oxford vaccine continued to outweigh the risk of side effects.
The EMA also reminded the public that of the very few cases of blood clots, most were combined with low levels of blood platelets and were within two weeks of vaccination.
Britain’s medical watchdog, the Medicines & Healthcare products Regulatory Agency (MHRA), said the overall incidence of blood clots with low platelets after a first dose of Astrazeneca is put at 10.5 per million doses, and about one in a million for a second dose.
There have been 49 deaths in the UK, meaning the odds of someone getting a fatal blood clot is 2.1 per million.
But this goes up to 4.5 for those aged 30 to 39.
England’s deputy chief medical officer Professor Jonathan Van-Tam has previously described the blood clots as “vanishingly rare” but “quite serious”.
The same kind of blood clotting cases have been seen in Europe.
And there are cases in the US after having the Johnson & Johnson vaccine – which uses the same technology as the AZ jab but is not being used in Europe or the UK.